Butterfly Network Appoints Dr. Arun Nagdev as Chief Medical Officer
New role to lead global strategy and expand point-of-care ultrasound adoption
Butterfly Network (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced the appointment of Arun Nagdev, MD, as Chief Medical Officer – Point-of-Care Ultrasound (POCUS). In this role, Dr Nagdev will lead the global medical strategy for the Company’s core POCUS business, advancing clinical product validation, strengthening customer engagement, and supporting regulatory and clinical development efforts.
Dr. Nagdev brings more than 20 years of experience advancing POCUS adoption, education, and clinical standards worldwide. He currently serves as an attending physician and Director of Emergency Ultrasound at Highland General Hospital and as an Associate Clinical Professor of Emergency Medicine at the University of California, San Francisco. He has also held national leadership roles within leading professional organisations, including the American College of Emergency Physicians and the American Institute of Ultrasound in Medicine.
In addition to his clinical and academic leadership, Dr Nagdev brings deep experience at the intersection of ultrasound, artificial intelligence, and product development. He previously served as Vice President of Clinical at Exo and has advised global imaging companies, including Philips and Fujifilm SonoSite. He is also a widely published researcher and educator, with an influential body of peer-reviewed research and invited presentations worldwide.
“Arun is one of the most respected voices in point-of-care ultrasound, with a rare combination of clinical credibility, academic leadership, and product insight,” said Joseph DeVivo, President, CEO, and Chairman of Butterfly Network. “As we continue to scale our enterprise strategy and expand globally, his leadership will be critical to ensuring our technology delivers measurable clinical and economic value for customers.”
“Butterfly has fundamentally changed what’s possible with ultrasound through its semiconductor-based, software-defined platform,” said Dr. Nagdev. “I’m excited to join at a time when point-of-care ultrasound is becoming essential to care delivery across settings. The next phase will be defined by clinical standards and broader adoption, and I look forward to supporting that progression globally.”
